Butyric Acid

Butyric Acid

SCHEMBL1036067

CCCC(=O)[O-].CC[P+](CC)(CC)CC

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 3/20 0.74
HDAC3 O15379 3/20 0.74
HDAC1 Q13547 3/20 0.74
HDAC2 Q92769 3/20 0.74
HDAC8 Q9BY41 3/20 0.74
CA1 P00915 3/20 0.50
CA2 P00918 2/20 0.48
CES2 O00748 1/20 0.48
CES1 P23141 1/20 0.48
NFKB1 P19838 2/20 0.47
GPR84 Q9NQS5 1/20 0.45
FABP3 P05413 2/20 0.39
CYP3A4 P08684 1/20 0.39
TSHR P16473 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyric Acid SCHEMBL7613310 0.95 FFAR3 (0.67) FFAR3HDAC3HDAC1HDAC2HDAC8
Adipic Acid SCHEMBL8437395 0.84 CA1 (0.56) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL1035581 0.83 FFAR3 (0.82) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL1330878 0.83
Butyric Acid SCHEMBL9800297 0.83 FFAR3 (0.93) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL2587931 0.83 FFAR3 (0.93) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL11419652 0.83 FFAR3 (0.93) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL10908702 0.83 FFAR3 (0.93) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL4292004 0.83 FFAR3 (1.00) FFAR3HDAC3HDAC1HDAC2HDAC8
Butyric Acid SCHEMBL11441641 0.83 FFAR3 (0.93) FFAR3HDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112752786-B Polycarbonate compositions with improved oxidative stability and methods for preparing same SABIC环球技术有限责任公司 2023-06-09 CN claimed
US-7122613-B1 Method for the production of polycarbonates GENERAL ELECTRIC COMPANY (US) 2006-10-17 US claimed
EP-1578840-A1 METHOD FOR THE PRODUCTION OF POLYCARBONATES General Electric Company (US) 2005-09-28 EP claimed
WO-2004060963-A1 METHOD FOR THE PRODUCTION OF POLYCARBONATES GENERAL ELECTRIC COMPANY (US) 2004-07-22 WO claimed
US-20260118767-A1 REVERSE PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-04-30 US disclosed
US-20260044081-A1 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-02-12 US disclosed
EP-4692941-A2 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS Shin-Etsu Chemical Co., Ltd. (JP) 2026-02-11 EP disclosed
US-20250340697-A1 METHOD FOR THE MANUFACTURE OF POLYCARBONATE SABIC GLOBAL TECHNOLOGIES BV (NL) 2025-11-06 US disclosed
EP-4621486-A2 POLYVALENT AMMONIUM SALT COMPOUND, COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-09-24 EP disclosed
US-20250289931-A1 POLYVALENT AMMONIUM SALT COMPOUND, COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-09-18 US disclosed
EP-4592299-A1 SILICON-CONTAINING SULFONIUM SALT COMPOUND, COMPOSITION FOR FORMING A SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-07-30 EP disclosed
US-20250237953-A1 SILICON-CONTAINING SULFONIUM SALT COMPOUND, COMPOSITION FOR FORMING A SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS SHIN-ETSU CHEMICAL CO., LTD. (JP) 2025-07-24 US disclosed
US-6228973-B1 REACTING A DIHYDRIC PHENOL AND A DIHYDROCARBYL CARBONATE BY SOLVENT-FREE MELT POLYMERIZATION CATALYZED BY A TETRAORGANOPHOSPHONIUM SALT AND A LOWER CONCENTRATION OF ALKALI/ALKALINE EARTH COMPOUND; BY-PRODUCT INHIBITION GENERAL ELECTRIC COMPANY 2001-05-08 US disclosed
EP-1069146-A1 POLYCARBONATE AND OPTICAL MATERIAL Idemitsu Petrochemical Co., Ltd. (JP) 2001-01-17 EP disclosed
EP-1035150-A1 COPOLYCARBONATE AND PROCESS FOR PRODUCING THE SAME IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2000-09-13 EP disclosed
EP-0702044-B1 Polycarbonate redistribution method GEN ELECTRIC (US) 2000-05-03 EP disclosed
EP-0702044-A1 Polycarbonate redistribution method GENERAL ELECTRIC COMPANY (US) 1996-03-20 EP disclosed
US-5459226-A Melt extrusion in presence of tetraorganophosphonium carboxylate salt GENERAL ELECTRIC COMPANY (US) 1995-10-17 US disclosed
EP-0671428-A1 Method for making polycarbonates GENERAL ELECTRIC COMPANY (US) 1995-09-13 EP disclosed
US-5412061-A Polycarbonate melt condensation synthesis using a tetraorganophosphonium carboxylate salt catalyst GENERAL ELECTRIC COMPANY (US) 1995-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250289931-A1 POLYVALENT AMMONIUM SALT COMPOUND, COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS ASH2L, PUF60, IDUA FFAR3 1313/4885HDAC3 2829/4885HDAC1 1279/4885
US-20260118767-A1 REVERSE PATTERNING PROCESS EFNA1, EPHA4, ETV6 FFAR3 2087/4885HDAC3 4451/4885HDAC1 4383/4885
US-20260044081-A1 COMPOSITION FOR FORMING SILICON-CONTAINING RESIST FILM AND PATTERNING PROCESS SMC1A, SPOUT1, LBR FFAR3 110/4885HDAC3 2256/4885HDAC1 497/4885
US-20250237953-A1 SILICON-CONTAINING SULFONIUM SALT COMPOUND, COMPOSITION FOR FORMING A SILICON-CONTAINING RESIST UNDERLAYER FILM, AND PATTERNING PROCESS SMURF1, OSR1, SIK1 FFAR3 2578/4885HDAC3 3742/4885HDAC1 1298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.